4

SIECZKAREK PURCHASE

Company: NovaBay Pharmaceuticals, Inc.
Filed: March 5, 2015
Period of Report: March 3, 2015
Accession Number: 0001437749-15-004222

View Document ↗ View on SEC.gov ↗